2019 ASH指南:免疫性血小板减少症

2019-12-01 美国血液病学会 Blood Adv. 2019 Dec 10;3(23):3829-3866.

2019年12月,美国血液病学会(ASH)发布了免疫性血小板减少症管理指南。ASH专家组共形成了21条循证指导建议,内容涉及新诊断,持续性以及一线疗法难治的无出血性生命危险的成人和儿童免疫性血小板减少症的管理。治疗方法包括:观察,皮质类固醇类药物,IV免疫球蛋白,抗-D免疫球蛋白,英夫利昔单抗,脾切除以及血小板生成素受体激动剂。

中文标题:

2019 ASH指南:免疫性血小板减少症

英文标题:

American Society of Hematology 2019 guidelines for immune thrombocytopenia.

发布机构:

美国血液病学会

发布日期:

2019-12-01

简要介绍:

2019年12月,美国血液病学会(ASH)发布了免疫性血小板减少症管理指南。ASH专家组共形成了21条循证指导建议,内容涉及新诊断,持续性以及一线疗法难治的无出血性生命危险的成人和儿童免疫性血小板减少症的管理。治疗方法包括:观察,皮质类固醇类药物,IV免疫球蛋白,抗-D免疫球蛋白,英夫利昔单抗,脾切除以及血小板生成素受体激动剂。

 

拓展指南:血小板相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 ASH指南:免疫性血小板减少症)] GetToolGuiderByIdResponse(projectId=1, id=687521c00183e332, title=2019 ASH指南:免疫性血小板减少症, enTitle=American Society of Hematology 2019 guidelines for immune thrombocytopenia., guiderFrom=Blood Adv. 2019 Dec 10;3(23):3829-3866., authorId=null, author=, summary=2019年12月,美国血液病学会(ASH)发布了免疫性血小板减少症管理指南。ASH专家组共形成了21条循证指导建议,内容涉及新诊断,持续性以及一线疗法难治的无出血性生命危险的成人和儿童免疫性血小板减少症的管理。治疗方法包括:观察,皮质类固醇类药物,IV免疫球蛋白,抗-D免疫球蛋白,英夫利昔单抗,脾切除以及血小板生成素受体激动剂。 , cover=, journalId=null, articlesId=null, associationId=25, associationName=美国血液病学会, associationIntro=美国血液病学会---是全球最大的关于血液疾病病因及治疗的专业协会。其使命为通过促进血液学的研究、临床护理、教育、培训及宣传而进一步促进对血液、骨髓、免疫、凝血及脉管系统疾病的了解、诊断与防治。ASH的官方杂志为《血液》,是该领域被引用最多的同行评议杂志,周刊。, copyright=0, guiderPublishedTime=Sun Dec 01 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年12月,美国血液病学会(ASH)发布了免疫性血小板减少症管理指南。ASH专家组共形成了21条循证指导建议,内容涉及新诊断,持续性以及一线疗法难治的无出血性生命危险的成人和儿童免疫性血小板减少症的管理。治疗方法包括:观察,皮质类固醇类药物,IV免疫球蛋白,抗-D免疫球蛋白,英夫利昔单抗,脾切除以及血小板生成素受体激动剂。</P> <P> </P>拓展指南:<strong>与<font color=red>血小板</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=954861c00180eae0" title="发热伴血小板减少综合征中西医结合诊疗专家共识" target=_blank>发热伴血小板减少综合征中西医结合诊疗专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=b4e2c1c001e73963" title="急性冠状动脉综合征非血运重建患者抗血小板治疗中国专家共识(2018)" target=_blank>急性冠状动脉综合征非血运重建患者抗血小板治疗中国专家共识(2018)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=f130e1c001e1a7ff" title="2019 ACOG实践简报:妊娠期血小板减少症(No.207)" target=_blank>2019 ACOG实践简报:妊娠期血小板减少症(No.207)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=d4b9f1c00169582a" title="2019 BSH最佳实践指南:接受类固醇治疗的免疫血小板减少症患者糖皮质激素性骨质疏松症的预防" target=_blank>2019 BSH最佳实践指南:接受类固醇治疗的免疫血小板减少症患者糖皮质激素性骨质疏松症的预防</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=4f88f1c0016e277b" title="2018 ASH静脉血栓栓塞管理指南:肝素诱导的血小板减少症" target=_blank>2018 ASH静脉血栓栓塞管理指南:肝素诱导的血小板减少症</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E8%A1%80%E5%B0%8F%E6%9D%BF" target=_blank>有关血小板更多指南</a></ul>, tagList=[TagDto(tagId=34037, tagName=免疫性血小板减少症)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10049, appHits=669, showAppHits=28, pcHits=3354, showPcHits=7933, likes=57, shares=40, comments=6, approvalStatus=1, publishedTime=Mon Dec 09 23:00:46 CST 2019, publishedTimeString=2019-12-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Dec 09 23:00:46 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 16:16:46 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 ASH指南:免疫性血小板减少症)])
2019 ASH指南:免疫性血小板减少症
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1069807, encodeId=0a6c106980ed0, content=中文的在哪, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28af5709064, createdName=ms3000000720850248, createdTime=Sat Nov 13 08:55:10 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061881, encodeId=00ee106188151, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 16:38:07 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058134, encodeId=04561058134b8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5e82466251, createdName=1242a32cm95暂无昵称, createdTime=Wed Oct 06 16:12:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053286, encodeId=8051105328665, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIbGiaLHIGeT8QLJiciaLmSNBA9iczxghI85OWMLWV4yKc0MgK9aztyjFSFHdLrdjvcoIOTNnzVPj0BRQ/132, createdBy=94ee5142021, createdName=氟西西, createdTime=Mon Sep 20 16:30:44 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007849, encodeId=b859100e849ff, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75533839, createdName=viruswl, createdTime=Sat Aug 14 14:52:34 CST 2021, time=2021-08-14, status=1, ipAttribution=)]
    2021-11-13 ms3000000720850248

    中文的在哪

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1069807, encodeId=0a6c106980ed0, content=中文的在哪, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28af5709064, createdName=ms3000000720850248, createdTime=Sat Nov 13 08:55:10 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061881, encodeId=00ee106188151, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 16:38:07 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058134, encodeId=04561058134b8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5e82466251, createdName=1242a32cm95暂无昵称, createdTime=Wed Oct 06 16:12:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053286, encodeId=8051105328665, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIbGiaLHIGeT8QLJiciaLmSNBA9iczxghI85OWMLWV4yKc0MgK9aztyjFSFHdLrdjvcoIOTNnzVPj0BRQ/132, createdBy=94ee5142021, createdName=氟西西, createdTime=Mon Sep 20 16:30:44 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007849, encodeId=b859100e849ff, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75533839, createdName=viruswl, createdTime=Sat Aug 14 14:52:34 CST 2021, time=2021-08-14, status=1, ipAttribution=)]
    2021-10-19 湘雅科教

    不错

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1069807, encodeId=0a6c106980ed0, content=中文的在哪, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28af5709064, createdName=ms3000000720850248, createdTime=Sat Nov 13 08:55:10 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061881, encodeId=00ee106188151, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 16:38:07 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058134, encodeId=04561058134b8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5e82466251, createdName=1242a32cm95暂无昵称, createdTime=Wed Oct 06 16:12:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053286, encodeId=8051105328665, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIbGiaLHIGeT8QLJiciaLmSNBA9iczxghI85OWMLWV4yKc0MgK9aztyjFSFHdLrdjvcoIOTNnzVPj0BRQ/132, createdBy=94ee5142021, createdName=氟西西, createdTime=Mon Sep 20 16:30:44 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007849, encodeId=b859100e849ff, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75533839, createdName=viruswl, createdTime=Sat Aug 14 14:52:34 CST 2021, time=2021-08-14, status=1, ipAttribution=)]
    2021-10-06 1242a32cm95暂无昵称

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1069807, encodeId=0a6c106980ed0, content=中文的在哪, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28af5709064, createdName=ms3000000720850248, createdTime=Sat Nov 13 08:55:10 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061881, encodeId=00ee106188151, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 16:38:07 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058134, encodeId=04561058134b8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5e82466251, createdName=1242a32cm95暂无昵称, createdTime=Wed Oct 06 16:12:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053286, encodeId=8051105328665, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIbGiaLHIGeT8QLJiciaLmSNBA9iczxghI85OWMLWV4yKc0MgK9aztyjFSFHdLrdjvcoIOTNnzVPj0BRQ/132, createdBy=94ee5142021, createdName=氟西西, createdTime=Mon Sep 20 16:30:44 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007849, encodeId=b859100e849ff, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75533839, createdName=viruswl, createdTime=Sat Aug 14 14:52:34 CST 2021, time=2021-08-14, status=1, ipAttribution=)]
    2021-09-20 氟西西

    谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1069807, encodeId=0a6c106980ed0, content=中文的在哪, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28af5709064, createdName=ms3000000720850248, createdTime=Sat Nov 13 08:55:10 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061881, encodeId=00ee106188151, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 16:38:07 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058134, encodeId=04561058134b8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5e82466251, createdName=1242a32cm95暂无昵称, createdTime=Wed Oct 06 16:12:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053286, encodeId=8051105328665, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIbGiaLHIGeT8QLJiciaLmSNBA9iczxghI85OWMLWV4yKc0MgK9aztyjFSFHdLrdjvcoIOTNnzVPj0BRQ/132, createdBy=94ee5142021, createdName=氟西西, createdTime=Mon Sep 20 16:30:44 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007849, encodeId=b859100e849ff, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac75533839, createdName=viruswl, createdTime=Sat Aug 14 14:52:34 CST 2021, time=2021-08-14, status=1, ipAttribution=)]
    2021-08-14 viruswl

    谢谢分享

    0